Success Metrics

Clinical Success Rate
95.0%

Based on 19 completed trials

Completion Rate
95%(19/20)
Active Trials
0(0%)
Results Posted
32%(6 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
4
18%
Ph phase_1
5
23%
Ph phase_4
4
18%
Ph phase_3
8
36%

Phase Distribution

5

Early Stage

4

Mid Stage

12

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
5(23.8%)
Phase 2Efficacy & side effects
4(19.0%)
Phase 3Large-scale testing
8(38.1%)
Phase 4Post-market surveillance
4(19.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.0%

19 of 20 finished

Non-Completion Rate

5.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

22

all time

Status Distribution
Completed(19)
Terminated(1)
Other(2)

Detailed Status

Completed19
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
0
Success Rate
95.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (23.8%)
Phase 24 (19.0%)
Phase 38 (38.1%)
Phase 44 (19.0%)

Trials by Status

completed1986%
terminated15%
unknown29%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT03038308Phase 1

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Completed
NCT03176966Phase 4

Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis

Completed
NCT03806530Phase 3

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

Completed
NCT03708237Phase 2

Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD

Terminated
NCT01435915Phase 1

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

Completed
NCT00419692Phase 1

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

Completed
NCT01327339

REQUIP RLS Post Marketing Surveillance

Completed
NCT00314821Phase 4

Ropinirole in the Treatment of Bipolar Depression

Completed
NCT00329602Phase 4

Long-term Study Of Ropinirole In Restless Legs Syndrome

Completed
NCT00381472Phase 3

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

Completed
NCT00460148Phase 2

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

Completed
NCT00363857Phase 3

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

Completed
NCT00256893Phase 2

Fibromyalgia Study In Adults

Completed
NCT00225862Phase 3

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Completed
NCT01628926Phase 3

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

Completed
NCT01627847Phase 1

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition

Completed
NCT01627834Phase 1

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition

Completed
NCT00357097Phase 3

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Completed
NCT00367822Phase 3

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

Completed
NCT00639119Phase 2

Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
22